B3QZN3

PR
Gene name
tsf
Protein name
Elongation factor Ts
Names
EF-Ts
Species
Phytoplasma mali (strain AT)
KEGG Pathway
pml:ATP_00233
EC number
Protein Class

Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

171-242 (Predicted disordered autoinhibitory region) PR

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

References

Autoinhibited structure

Activated structure

1 structures for B3QZN3

Entry ID Method Resolution Chain Position Source
AF-B3QZN3-F1 Predicted AlphaFoldDB

No variants for B3QZN3

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for B3QZN3

No associated diseases with B3QZN3

2 regional properties for B3QZN3

Type Name Position InterPro Accession
domain Translation elongation factor EFTs/EF1B, dimerisation 70 - 277 IPR014039
conserved_site Translation elongation factor Ts, conserved site 74 - 84 IPR018101

Functions

Description
EC Number
Subcellular Localization
  • Cytoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

1 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.

1 GO annotations of molecular function

Name Definition
translation elongation factor activity Functions in chain elongation during polypeptide synthesis at the ribosome.

No GO annotations of biological process

Name Definition
No GO annotations for biological process

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MQFDVEKIKF LRNKTQAGIM DCQKALINSK GDIDQAIIFL RKQGIKKASE ITGKILGEGL
70 80 90 100 110 120
TNVIIDNNEA VLYELNSETD FVAKNKIFLD LLNLLGKILL KETKPNMNID EILNLKFEDK
130 140 150 160 170 180
KIKDLLLEKT AIVQEKICLR KVIKVIKKDD ENFGMYKHQN GFISVLVITK NSKKDVSEDI
190 200 210 220 230 240
AMHIAANKPK FINKEQVDLE TLNQEKSIIE AQVNKELGNE KTFNIKEKII EGRLNKFIQN
250 260 270
ICLIEQSFVK NPEQKLRDYL KEKEVEIINY WRLEVGERI